Roles of cMET/ErbB3 activation and overexpression in the development or resistance to EGFR inhibitors in NSCLC patients.

被引：0
|
作者：
Ahn, Myung-Ju
Park, Silvia
Sun, Jong-Mu
Ahn, Jin Seok
Park, Keunchil
Langley, Emma J.
Kim, Phillip Sangwook
Singh, Sharat
Lockton, Steve
机构：
[1] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Seoul, South Korea
[2] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Div Hematol Oncol,Dept Med, Seoul, South Korea
[3] Prometheus Labs Inc, San Diego, CA USA
[4] Prometheus Therapeut & Diagnost, San Diego, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2013年 / 31卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
11113
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Activation of Putative Compensatory Pathways upon Deletion of Erbb3 in Mutant EGFR-driven Lung Cancer
    Song, Xiaoling
    Fan, Pang-Dian
    Guha, Udayan
    Threadgill, David
    Varmus, Harold
    Politi, Katerina
    CLINICAL CANCER RESEARCH, 2012, 18 (03)
  • [32] The disruption of heregulin, ErbB2, and ErbB3 genes leads to cardiac and neural abnormalities: roles in development and adulthood.
    Erickson, SL
    FASEB JOURNAL, 1998, 12 (05): : A1104 - A1104
  • [33] Ligand-Independent EGFR Activation by Anchorage-Stimulated Src Promotes Cancer Cell Proliferation and Cetuximab Resistance via ErbB3 Phosphorylation
    Nozaki, Masami
    Yasui, Hiroki
    Ohnishi, Yuichi
    CANCERS, 2019, 11 (10)
  • [34] Plasma microRNA signatures to predict EGFR-TKI resistance in EGFR-mutant advanced NSCLC patients.
    Wang, Shuhang
    Wang, Jie
    Bai, Hua
    An, Tongtong
    Zhao, Jun
    Wang, Zhijie
    Duan, Jianchun
    Zhuo, Minglei
    Wang, Yuyan
    Wu, Meina
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [35] Analysis of resistance mechanisms to ALK kinase inhibitors in ALK plus NSCLC patients.
    Doebele, Robert Charles
    Aisner, Dara L.
    Le, Anh T.
    Berge, Eamon M.
    Pilling, Amanda B.
    Kutateladze, Tatiana G.
    Weickhardt, Andrew James
    Franklin, Wilbur A.
    Varella-Garcia, Marileila
    Camidge, D. Ross
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [36] ERBB3/HER2 Signaling Promotes Resistance to EGFR Blockade in Head and Neck and Colorectal Cancer Models
    Zhang, Li
    Castanaro, Carla
    Luan, Bo
    Yang, Katie
    Fan, Liangfen
    Fairhurst, Jeanette L.
    Rafique, Ashique
    Potocky, Terra B.
    Shan, Jing
    Delfino, Frank J.
    Shi, Ergang
    Huang, Tammy
    Martin, Joel H.
    Chen, Gang
    MacDonald, Douglas
    Rudge, John S.
    Thurston, Gavin
    Daly, Christopher
    MOLECULAR CANCER THERAPEUTICS, 2014, 13 (05) : 1345 - 1355
  • [37] Outcome of EGFR-mutated NSCLC patients with MET-driven resistance to EGFR tyrosine kinase inhibitors
    Baldacci, Simon
    Mazieres, Julien
    Tomasini, Pascale
    Girard, Nicolas
    Guisier, Florian
    Audigier-Valette, Clarisse
    Monnet, Isabelle
    Wislez, Marie
    Perol, Maurice
    Do, Pascal
    Dansin, Eric
    Leduc, Charlotte
    Leprieur, Etienne Giroux
    Moro-Sibilot, Denis
    Tulasne, David
    Kherrouche, Zoulika
    Labreuche, Julien
    Cortot, Alexis B.
    ONCOTARGET, 2017, 8 (62) : 105103 - 105114
  • [38] Overexpression of ErbB2 and ErbB3 receptors in Schwann cells of patients with Charcot-Marie-Tooth disease type 1A
    Massa, R
    Palumbo, C
    Cavallaro, T
    Panico, MB
    Bei, R
    Terracciano, C
    Rizzuto, N
    Bernardi, G
    Modesti, A
    MUSCLE & NERVE, 2006, 33 (03) : 342 - 349
  • [39] Combating acquired resistance to KRAS inhibitors in NSCLC by targeting PTPRR-mediated activation of EGFR signaling
    Kanemura, Hiroaki
    Takehara, Toshiyuki
    Onodera, Yuta
    Teramura, Takeshi
    Suzuki, Shinichiro
    Sakai, Kazuko
    Nishio, Kazuto
    Nakagawa, Kazuhiko
    Hayashi, Hidetoshi
    Yonesaka, Kimio
    CANCER SCIENCE, 2024, 115 : 422 - 422
  • [40] Human epidermal receptor family inhibitors in patients with ERBB3 mutated cancers: Entering the back door
    Verlingue, Loic
    Hollebecque, Antoine
    Lacroix, Ludovic
    Postel-Vinay, Sophie
    Varga, Andrea
    El Dakdouki, Yolla
    Baldini, Capucine
    Balheda, Rastilav
    Gazzah, Anas
    Michot, Jean-Marie
    Marabelle, Aurelien
    Mir, Olivier
    Arnedos, Monica
    Rouleau, Etienne
    Solary, Eric
    De Baere, Thierry
    Angevin, Eric
    Armand, Jean-Pierre
    Michiels, Stefan
    Andre, Fabrice
    Deutsch, Eric
    Scoazec, Jean-Yves
    Soria, Jean-Charles
    Massard, Christophe
    EUROPEAN JOURNAL OF CANCER, 2018, 92 : 1 - 10
12345